ArticleEuropean radiology2026
A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo compare tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage. MATERIALS AND
methodsIn this retrospective study, women screened with mammography between 1/4/2017 and 30/3/2020 at one site were included. Tumour characteristics were compared for screen-detected and interval cancers with breast density (Volpara) and AJCC (8th edition) prognostic stage for interval cancers. Categorical variables were compared using Pearson's χ², Fisher's exact, or binomial tests.
resultsFrom 55,010 attendees, 723 cancers were diagnosed (463 screen-detected; 260 interval). Time to interval cancer diagnosis was longer in women with dense breasts compared with non-dense breasts (median: 767 vs 624 days; p = 0.04). Earlier stage interval cancers ( < IIA) were more likely diagnosed in the second and third year compared to year 1 ((33/78) 48.7% and (56/129) 43.4% vs (12/53) 22.6%; p = 0.02). Retrospectively missed interval cancers were less frequent in women with dense breasts compared with true interval cancers (41.4% vs 71.9%); p < 0.01. Retrospectively missed intervals were more likely than true intervals to be grade 3 ((15/29) 51.7% vs (64/196) 32.7%, p = 1.00), lymph node positive ((12/29) 41.4% vs (70/196) 35.7%, p ≥ 0.7) and ≥ stage IIA ((14/29) 48.3% vs (72/196) 36.7%, ≥ IIA, p = 0.68).
conclusionsThe time to interval cancer diagnosis was longer for women with dense breasts. Interval cancers presenting within the first year after screening had the worst prognosis. Retrospectively missed interval cancers had worse prognostic features and were more likely in non-dense breasts. KEY POINTS: Question To establish the relationship between screen-detected and interval cancers and breast density, and the prognosis of interval cancers depending on time of diagnosis and radiological signs. Findings Interval cancers presented later in women with dense breasts, but prognostically worse cancers presented earlier and were more likely to demonstrate retrospectively visible mammographic signs. Clinical relevance Our finding that prognostically worse interval cancers were most likely in the first year after screening, and when radiological signs were retrospectively present, identifies an important opportunity for AI-based tools to enhance screening programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.